Volume 58, Issue 2, Pages (April 2015)

Slides:



Advertisements
Similar presentations
GCN5 Regulates FGF Signaling and Activates Selective MYC Target Genes during Early Embryoid Body Differentiation  Li Wang, Evangelia Koutelou, Calley.
Advertisements

Volume 46, Issue 5, Pages (June 2012)
Establishment of Endoderm Progenitors by SOX Transcription Factor Expression in Human Embryonic Stem Cells  Cheryle A. Séguin, Jonathan S. Draper, Andras.
Volume 52, Issue 4, Pages (November 2013)
Volume 47, Issue 2, Pages (July 2012)
Volume 15, Issue 3, Pages (September 2014)
Volume 11, Issue 2, Pages (August 2012)
Volume 14, Issue 5, Pages (May 2014)
Volume 16, Issue 9, Pages (August 2016)
Volume 4, Issue 4, Pages (April 2015)
Volume 44, Issue 3, Pages (November 2011)
Kobe C. Yuen, Baoshan Xu, Ian D. Krantz, Jennifer L. Gerton 
Volume 68, Issue 1, Pages e5 (October 2017)
Volume 29, Issue 1, Pages (April 2014)
Volume 19, Issue 3, Pages (April 2017)
Volume 29, Issue 4, Pages (May 2014)
Integrative Analysis of the Acquisition of Pluripotency in PGCs Reveals the Mutually Exclusive Roles of Blimp-1 and AKT Signaling  Go Nagamatsu, Shigeru.
Volume 3, Issue 5, Pages (November 2014)
Volume 13, Issue 6, Pages (December 2013)
The Translational Landscape of the Mammalian Cell Cycle
Volume 17, Issue 4, Pages (October 2015)
Dynamic change of transcription pausing through modulating NELF protein stability regulates granulocytic differentiation by Xiuli Liu, Aishwarya A. Gogate,
Volume 11, Issue 4, Pages (October 2018)
Volume 2, Issue 2, Pages (February 2008)
Volume 9, Issue 3, Pages (September 2017)
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites to Alter the Breast Cancer Cell Transcriptome  Hector L. Franco, Anusha Nagari, W. Lee Kraus 
Volume 10, Issue 1, Pages (January 2018)
Volume 19, Issue 3, Pages (August 2005)
Volume 143, Issue 4, Pages (November 2010)
Volume 67, Issue 6, Pages e6 (September 2017)
Volume 46, Issue 1, Pages (April 2012)
Volume 7, Issue 4, Pages (October 2016)
Wei Jiang, Yuting Liu, Rui Liu, Kun Zhang, Yi Zhang  Cell Reports 
Volume 4, Issue 1, Pages (January 2015)
Volume 44, Issue 3, Pages (November 2011)
Volume 62, Issue 1, Pages (April 2016)
Volume 1, Issue 6, Pages (December 2013)
Volume 9, Issue 5, Pages (November 2017)
Volume 16, Issue 9, Pages (August 2016)
Volume 54, Issue 5, Pages (June 2014)
Volume 13, Issue 6, Pages (December 2013)
Volume 8, Issue 5, Pages (May 2017)
SMADs and YAP Compete to Control Elongation of β-Catenin:LEF-1-Recruited RNAPII during hESC Differentiation  Conchi Estarás, Chris Benner, Katherine A.
Volume 46, Issue 5, Pages (June 2012)
An RNAi Screen of Chromatin Proteins Identifies Tip60-p400 as a Regulator of Embryonic Stem Cell Identity  Thomas G. Fazzio, Jason T. Huff, Barbara Panning 
Volume 50, Issue 2, Pages (April 2013)
Volume 21, Issue 9, Pages (November 2017)
Volume 13, Issue 1, Pages (October 2015)
Volume 66, Issue 4, Pages e4 (May 2017)
Xudong Wu, Jens Vilstrup Johansen, Kristian Helin  Molecular Cell 
Polycomb Protein Ezh1 Promotes RNA Polymerase II Elongation
Volume 55, Issue 5, Pages (September 2014)
Xuepei Lei, Jianwei Jiao  Stem Cell Reports 
Volume 55, Issue 5, Pages (September 2014)
Volume 20, Issue 13, Pages (September 2017)
DNA Looping Facilitates Targeting of a Chromatin Remodeling Enzyme
Laralynne Przybyla, Johnathon N. Lakins, Valerie M. Weaver 
Volume 19, Issue 3, Pages (August 2005)
Volume 4, Issue 1, Pages (July 2013)
Short Telomeres in ESCs Lead to Unstable Differentiation
Keriayn N. Smith, Amar M. Singh, Stephen Dalton  Cell Stem Cell 
Volume 29, Issue 3, Pages (March 2016)
CNOT3-Dependent mRNA Deadenylation Safeguards the Pluripotent State
Volume 9, Issue 5, Pages (November 2017)
Volume 17, Issue 3, Pages (October 2016)
Volume 20, Issue 13, Pages (September 2017)
Volume 64, Issue 5, Pages (December 2016)
Volume 24, Issue 8, Pages e7 (August 2018)
Volume 71, Issue 2, Pages e5 (July 2018)
Yasuhiro Yamada, Hitomi Aoki, Takahiro Kunisada, Akira Hara 
Presentation transcript:

Volume 58, Issue 2, Pages 311-322 (April 2015) Pausing of RNA Polymerase II Regulates Mammalian Developmental Potential through Control of Signaling Networks  Lucy H. Williams, George Fromm, Nolan G. Gokey, Telmo Henriques, Ginger W. Muse, Adam Burkholder, David C. Fargo, Guang Hu, Karen Adelman  Molecular Cell  Volume 58, Issue 2, Pages 311-322 (April 2015) DOI: 10.1016/j.molcel.2015.02.003 Copyright © 2015 Elsevier Inc. Terms and Conditions

Molecular Cell 2015 58, 311-322DOI: (10.1016/j.molcel.2015.02.003) Copyright © 2015 Elsevier Inc. Terms and Conditions

Figure 1 Pol II Pausing is Enriched at ESC Genes Involved in Cell Cycle Regulation and Proliferation (A) Heatmap depiction of sense-strand GRO-seq reads around mouse RefSeq TSSs, ranked by decreasing promoter GRO-seq signal (±150 nt). The number of genes used for each heatmap is noted at top; developmental genes include GO terms, 0045165, 0048864, 0007498; bivalent genes were defined in Ku et al. (2008); and cell cycle genes are from GO term 0007049. Green arrows depict the position in each heatmap where promoter GRO-seq signal fails to be statistically significant (p < 0.001), and the position of selected pluripotency and lineage markers is shown. Blue tick marks at left of developmental heatmap denote developmental genes characterized as bivalent. (B) Average sense-strand GRO-seq signal around all genes as compared to the signal derived from genes in each group described in (A). (C) Pol II distribution at genes with significant promoter Pol II signal is shown as heatmaps ranked by decreasing Pausing Index. Blue arrows depict the point at which the Pausing Index drops below 4. (D) Comparison of Pausing Indices across gene groups reveals significantly lower levels of pausing among bivalent genes and higher levels among cell cycle genes (as compared to all genes; p values are from Mann-Whitney U test). (E–G) Examples of GRO-seq signal at (E) the pluripotency gene Sox2 and lineage markers Eomes and Gata4, (F) bivalent genes Lhx5 and Klf4, or (G) cell cycle genes caspase-3 (Casp3) and C-Myb (Mybl2). Gene models are shown below with TSSs designated by arrows. See also Figure S1. Molecular Cell 2015 58, 311-322DOI: (10.1016/j.molcel.2015.02.003) Copyright © 2015 Elsevier Inc. Terms and Conditions

Figure 2 GRO-seq and Pol II ChIP-seq Data Sets Show Similar Pol II Profiles (A) Heatmap depiction of Pol II ChIP-seq reads (total Pol II antibody; data from Rahl et al., 2010) from ESCs grown in serum-containing conditions. Genes are aligned around mouse RefSeq TSSs and ranked by decreasing promoter Pol II ChIP-seq signal (±150 bp). Gene groups are shown as in Figure 1A. (B) Composite Pol II ChIP-seq signal around all genes (black) as compared to the signal derived from developmental genes (green), bivalent genes (blue), and cell cycle regulators (red). Data sets represent Pol II ChIP-seq using a total Pol II antibody (Rahl et al., 2010) in serum-grown ESCs (as in Figure 2A) and Pol II ChIP-seq from 2i or serum conditions using the 8WG16 antibody that enriches in Pol II with a hypophosphorylated CTD (Marks et al., 2012). (C) Gene examples that broadly display pausing across data sets, Vegfa (left), and a gene with little signal in any data set, Brachyury (right). Data are GRO-seq in 2i (this work) or serum (Jonkers et al., 2014), Pol II ChIP-seq in 2i (Marks et al., 2012), or serum conditions (Rahl et al., 2010). See also Figure S2. Molecular Cell 2015 58, 311-322DOI: (10.1016/j.molcel.2015.02.003) Copyright © 2015 Elsevier Inc. Terms and Conditions

Figure 3 NELF-B Knockout in 2i Media Dysregulates Expression of Genes Involved in Proliferation, Signal Transduction and Metabolism (A) Western analysis shows that NELF-B and NELF-E proteins are lost with similar kinetics after conditional NELF-B KO ESCs are treated with 4OHT. Actin serves as a loading control. (B) Viable ESCs were counted at the time points shown to determine the effects of NELF-B KO on cell proliferation. (C) Images depict typical morphology of conditional NELF-B ESCs following vehicle or 4OHT treatment. Cells were split between day 5 and day 6, reflecting continued potential for self-renewal at this time point. (D) Examples of genes significantly affected by NELF-B KO in RNA-seq data. The distributions of sense-strand GRO-seq reads and RNA-seq reads for control and NELF-B KO ESCs are shown. Gene models are depicted with arrows indicating TSSs. (E) A list of 771 NELF-affected genes was examined using Ingenuity Pathway Analysis, and the top molecular and cellular functions categories were identified as shown. (F) Lists of Entrez gene IDs corresponding to 487 genes significantly downregulated (left) or 283 genes upregulated (right) upon loss of NELF-B was analyzed for enriched GO categories (p < 0.001). The top five GO categories for each class are shown. See also Table S1 and Figure S3. Molecular Cell 2015 58, 311-322DOI: (10.1016/j.molcel.2015.02.003) Copyright © 2015 Elsevier Inc. Terms and Conditions

Figure 4 Effects of NELF-B KO on Gene Expression Reflect Changes in Promoter Pol II (A) ChIP was performed to verify changes in Pol II distribution upon NELF-B KO. Percent input is shown for n = 3 clones ± SEM. Positions noted on the x axis denote the center point of each primer pair with respect to the TSS. Significant increases in Pol II signal within upregulated genes are noted by asterisks (p < 0.05). (B) Shown are the number and length of Start-RNA reads observed in control ESCs (n = 3) for genes unchanged, downregulated, or upregulated in RNA-seq analysis of NELF-B KO ESCs. The distribution of distances between the TSS (defined by the 5′ end of the Start-RNA) and the position of Pol II within the promoter region (defined by the Start-RNA 3′ end) is similar for all gene groups (no significant differences). However, both down- and upregulated genes display significantly more Start-RNA reads mapping near their promoters than genes unchanged by loss of NELF-B (downregulated versus unchanged p = 0.05; upregulated versus unchanged, p < 0.0001; Mann-Whitney U test). (C) Fold change in Start-RNA reads upon deletion of NELF-B at genes unchanged, downregulated, and upregulated by NELF-B KO in RNA-seq experiments. For this analysis, Start-RNA reads with 5′ ends mapping within 100 nt of RefSeq TSSs were counted using normalized (n = 3) data sets from control versus NELF-B KO ESCs. (D) TSSs with significantly fewer (left) or more (right) Start-RNAs upon loss of NELF-B were analyzed for enriched GO categories (p < 0.001), based on the Entrez gene ID associated with each affected TSS. The top five GO categories for each class are shown. See also Figure S4. Molecular Cell 2015 58, 311-322DOI: (10.1016/j.molcel.2015.02.003) Copyright © 2015 Elsevier Inc. Terms and Conditions

Figure 5 Ablation of NELF-B Renders ESCs Resistant to Differentiation in Serum (A) Alkaline phosphatase staining of control and NELF-B KO ESCs grown in serum on feeders (day 5 after treatment ± 4OHT). NELF-B KO ESCs display similar colony morphology and size, as well as equal staining intensity with alkaline phosphatase. (B) Quantitative RT-PCR analysis of mRNA in NELF-B KO ESCs grown in serum on feeders. Genes involved in proliferation and FGF/ERK signaling were similarly dysregulated in serum-exposed NELF-B KO ESCs as compared to ESCs grown in 2i. (C) Pluripotency marker expression is similar between control and NELF-B KO ESCs, while lineage-specific genes are unchanged, or even downregulated, in NELF-B KO cells grown in serum conditions. Markers represent endoderm (Endo.), ectoderm (Ecto.), mesoderm (Meso.), and trophectoderm (TE) lineages. Values shown represent n = 2 independent clones ± range, with control levels set as 1. (D) Bright-field images depict typical differences in morphology between control and NELF-B KO ESCs grown to high density in serum on feeders to induce spontaneous differentiation (day 5 after treatment ± 4OHT). Immunofluorescence is shown for DAPI, Nanog, and Gata4. Representative images are merged z stack sections, to show the absence of Gata4 within the entire field of view. See also Figure S5. Molecular Cell 2015 58, 311-322DOI: (10.1016/j.molcel.2015.02.003) Copyright © 2015 Elsevier Inc. Terms and Conditions

Figure 6 NELF-B KO ESCs are Refractory to FGF/ERK Signaling Upon Treatment with Fgf4, But are Induced to Differentiate with Constitutively Active ERK (A) Fgf4 stimulation of NELF-B KO ESCs fails to trigger phosphorylation of ERK (pERK). Cre control and NELF KO ESCs were cultured in serum for 4 days after 4OHT treatment, and Fgf4 was added to the media (10 ng/ml) for indicated times. Western analysis of phosphorylated and total ERK is shown, with NELF-B and GAPDH as loading controls. ERK antibodies recognize ERK1 (upper) and ERK2 (lower band). (B) Constitutively active ERK protein (CpERK) triggers differentiation and Gata4 expression in NELF-B KO ESCs. Cre control and conditional NELF-B KO ESCs were treated with 4OHT prior to transfection with CpERK. ESCs plated on feeders in serum-containing media were analyzed by immunofluorescence for DAPI and Gata4 on day 5 after 4OHT treatment. Images are merged z stack sections. (C) Analysis of mRNA levels for pluripotency (Oct4 and Nanog) and early differentiation (Fgf5 and Gata4) markers. Cre control and NELF-B KO ESCs were transfected with plasmids expressing GFP (control), or GFP and CpERK (CpERK). Transfected, GFP-positive cells were isolated by FACS and RNA analyzed by qRT-PCR. Values represent n = 3 clones ± SEM. See also Figure S6. Molecular Cell 2015 58, 311-322DOI: (10.1016/j.molcel.2015.02.003) Copyright © 2015 Elsevier Inc. Terms and Conditions

Figure 7 NELF-mediated Pausing of Pol II Regulates Developmental Signaling Cascades in ESCs Developmental signaling pathways converge on key transcription factors that enter the nucleus to activate genes involved in differentiation and cell-fate specification. (A) In the Drosophila embryo, many of the genes involved in morphogenesis and cell fate harbor paused Pol II (red, shown associated with NELF in orange, and a short, capped RNA transcript in blue). Pausing enables these promoters to be rapidly and synchronously induced by developmental cues. (B) In mouse ESCs, genes involved in lineage commitment do not frequently display Pol II pausing, perhaps allowing them to be more tightly repressed. Pausing is instead prevalent at active genes encoding signaling molecules, where NELF activity governs the expression and responsiveness of signal transduction machineries. Molecular Cell 2015 58, 311-322DOI: (10.1016/j.molcel.2015.02.003) Copyright © 2015 Elsevier Inc. Terms and Conditions